
Oncoclínicas do Brasil Serviços Médicos S.A.
B3:ONCO3.SA
5.06 (BRL) • At close July 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) BRL.
2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,566.04 | 1,634.891 | 1,567.63 | 1,458.666 | 1,434.246 | 1,401.548 | 1,359.523 | 1,293.459 | 1,216.528 | 1,163.872 | 899.9 | 807.952 | 767.879 | 679.42 | 640.215 | 614.552 | 574.319 | 524.858 | 482.655 | 453.359 |
Cost of Revenue
| 1,062.962 | 1,086.799 | 1,040.662 | 976.386 | 947.481 | 905.766 | 884.039 | 822.914 | 764.437 | 756.473 | 578.614 | 536.621 | 502.267 | 460.52 | 450.706 | 419.782 | 385.881 | 356.661 | 330.86 | 326.112 |
Gross Profit
| 503.078 | 548.092 | 526.968 | 482.28 | 486.765 | 495.782 | 475.484 | 470.545 | 452.091 | 407.399 | 321.286 | 271.331 | 265.612 | 218.9 | 189.509 | 194.77 | 188.438 | 168.197 | 151.795 | 127.247 |
Gross Profit Ratio
| 0.321 | 0.335 | 0.336 | 0.331 | 0.339 | 0.354 | 0.35 | 0.364 | 0.372 | 0.35 | 0.357 | 0.336 | 0.346 | 0.322 | 0.296 | 0.317 | 0.328 | 0.32 | 0.315 | 0.281 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0.037 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 412.919 | 355.756 | 311.121 | 316.967 | 303.865 | 308.746 | 288.221 | 271.237 | 255.198 | 277.121 | 248.094 | 200.404 | 194.532 | 18.408 | 335.529 | 139.581 | 248.869 | 112.286 | 118.267 | 115.673 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 412.919 | 355.756 | 311.121 | 316.967 | 303.865 | 308.746 | 288.221 | 271.237 | 255.198 | 277.121 | 248.094 | 200.404 | 194.532 | 18.408 | 335.529 | 139.581 | 248.869 | 112.286 | 118.267 | 115.673 |
Other Expenses
| 793.222 | 7.313 | 0 | 3.466 | 0 | 0 | 0 | -9.437 | -994.029 | 0 | 0 | -655.073 | 0 | 0 | 0 | -0.203 | 25.752 | 0.828 | 8.025 | 5.977 |
Operating Expenses
| 1,206.141 | 363.069 | 311.121 | 316.967 | 303.865 | 312.327 | 288.089 | 264.479 | -738.831 | 276.291 | 245.308 | -454.669 | 192.494 | 22.538 | 337.166 | 139.378 | -192.234 | 113.114 | 131.286 | 121.65 |
Operating Income
| -703.063 | 185.023 | 215.847 | 161.847 | 182.9 | 180.065 | 187.263 | 195.213 | 470.565 | 130.278 | 75.978 | 106.011 | 71.08 | 200.492 | -147.657 | 55.392 | -86.183 | 55.083 | 25.503 | 5.597 |
Operating Income Ratio
| -0.449 | 0.113 | 0.138 | 0.111 | 0.128 | 0.128 | 0.138 | 0.151 | 0.387 | 0.112 | 0.084 | 0.131 | 0.093 | 0.295 | -0.231 | 0.09 | -0.15 | 0.105 | 0.053 | 0.012 |
Total Other Income Expenses Net
| -13.592 | -135.976 | -179.99 | -186.95 | -63.758 | -142.12 | -116.774 | -120.271 | -405.437 | -95.386 | -70.469 | -90 | -20.469 | -32.719 | -36.133 | -27.65 | -12.546 | -14.949 | -15.132 | -14.491 |
Income Before Tax
| -716.655 | 49.047 | 35.857 | -25.103 | 119.142 | 37.945 | 70.489 | 74.942 | 65.128 | 34.892 | 5.509 | 16.011 | 50.611 | 167.773 | -183.79 | 27.742 | -98.729 | 40.134 | 10.371 | -8.894 |
Income Before Tax Ratio
| -0.458 | 0.03 | 0.023 | -0.017 | 0.083 | 0.027 | 0.052 | 0.058 | 0.054 | 0.03 | 0.006 | 0.02 | 0.066 | 0.247 | -0.287 | 0.045 | -0.172 | 0.076 | 0.021 | -0.02 |
Income Tax Expense
| 42.539 | 45.926 | 16.797 | -44.692 | 32.104 | -111.387 | 35.519 | 33.72 | -31.816 | -22.153 | 30.102 | 31.636 | 27.882 | 16.985 | 18.738 | 21.149 | 24.787 | 17.78 | 14.022 | 11.498 |
Net Income
| -643.144 | -15.94 | 3.302 | 9.592 | 75.439 | 104.989 | 21.006 | 22.184 | 71.114 | 30.833 | -32.694 | -22.993 | 15.292 | 145.177 | -204.888 | -2.481 | -142.614 | 14.069 | -9.327 | -21.747 |
Net Income Ratio
| -0.411 | -0.01 | 0.002 | 0.007 | 0.053 | 0.075 | 0.015 | 0.017 | 0.058 | 0.026 | -0.036 | -0.028 | 0.02 | 0.214 | -0.32 | -0.004 | -0.248 | 0.027 | -0.019 | -0.048 |
EPS
| -0.97 | -0.027 | 0.006 | 0.018 | 0.15 | 0.2 | 0.041 | 0.043 | 0.15 | 0.065 | -0.069 | -0.048 | 0.032 | 0.31 | -0.51 | -0.006 | -0.36 | 0.035 | -0.023 | -0.054 |
EPS Diluted
| -0.97 | -0.028 | 0.006 | 0.017 | 0.14 | 0.2 | 0.04 | 0.043 | 0.14 | 0.065 | -0.069 | -0.048 | 0.032 | 0.31 | -0.51 | -0.006 | -0.36 | 0.035 | -0.023 | -0.054 |
EBITDA
| -488.261 | 284.248 | 265.129 | 199.503 | 325.753 | 244.175 | 280.637 | 277.735 | 214.005 | 183.308 | 165.272 | 140.77 | 133.203 | 236.527 | -113.583 | 92.594 | -36.878 | 62.887 | 49.311 | 27.507 |
EBITDA Ratio
| -0.312 | 0.174 | 0.169 | 0.137 | 0.227 | 0.174 | 0.206 | 0.215 | 0.176 | 0.157 | 0.184 | 0.174 | 0.173 | 0.348 | -0.177 | 0.151 | -0.064 | 0.12 | 0.102 | 0.061 |